These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment. Mikkelsen LF; Rubak S BMC Pulm Med; 2020 Nov; 20(1):313. PubMed ID: 33243181 [TBL] [Abstract][Full Text] [Related]
5. Pseudotumor cerebri secondary to minocycline intake. Ang ER; Zimmerman JC; Malkin E J Am Board Fam Pract; 2002; 15(3):229-33. PubMed ID: 12038730 [TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections. Prescrire Int; 2009 Oct; 18(103):206. PubMed ID: 19882787 [TBL] [Abstract][Full Text] [Related]
7. Orofacial dyskinesia after moxifloxacin treatment--a case with normal hepatorenal function and review of literature. Mittal SO; Machado DG; Jabbari B Clin Neuropharmacol; 2012; 35(6):292-4. PubMed ID: 23151468 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous resolution of nitrofurantoin-induced chronic pulmonary toxicity presenting with respiratory failure. Mir E; Malik JA; Lone SA; Mohi-Ud-Din R; Khalil M Adv Respir Med; 2017; 85(6):333-338. PubMed ID: 29288483 [TBL] [Abstract][Full Text] [Related]
9. Pseudotumor cerebri induced by vitamin A combined with minocycline. Moskowitz Y; Leibowitz E; Ronen M; Aviel E Ann Ophthalmol; 1993 Aug; 25(8):306-8. PubMed ID: 8239326 [TBL] [Abstract][Full Text] [Related]
10. Electroconvulsive therapy and antibiotics: a case report. Reti IM; Davydow DS J ECT; 2007 Dec; 23(4):289-90. PubMed ID: 18090707 [TBL] [Abstract][Full Text] [Related]
11. Severe pseudomembranous colitis after moxifloxacin use: a case series. Gallagher JC; Du JK; Rose C Ann Pharmacother; 2009 Jan; 43(1):123-8. PubMed ID: 19066322 [TBL] [Abstract][Full Text] [Related]
12. Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases. Walter K; Tyler ME Cornea; 2006 Aug; 25(7):855-7. PubMed ID: 17068466 [TBL] [Abstract][Full Text] [Related]
13. [Novel side effects of moxifloxacin: making a balanced decision again]. Prins JM; Koopmans RP Ned Tijdschr Geneeskd; 2008 Aug; 152(34):1862-4. PubMed ID: 18788675 [TBL] [Abstract][Full Text] [Related]
14. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. Chang B; Knowles SR; Weber E Ann Pharmacother; 2010 Apr; 44(4):740-5. PubMed ID: 20233910 [TBL] [Abstract][Full Text] [Related]
15. Seven cases of autoimmune hepatitis that developed after drug-induced liver injury. Sugimoto K; Ito T; Yamamoto N; Shiraki K Hepatology; 2011 Nov; 54(5):1892-3. PubMed ID: 21725992 [No Abstract] [Full Text] [Related]
16. Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Biller P; Shank B; Lind L; Brennan M; Tkatch L; Killgore G; Thompson A; McDonald LC Infect Control Hosp Epidemiol; 2007 Feb; 28(2):198-201. PubMed ID: 17265402 [TBL] [Abstract][Full Text] [Related]
17. [Nitrofurantoin-induced lung disease: about two cases]. Mrozek N; Delèvaux I; Legendre M; André M; Trouillier S; Voinchet H; Aumaitre O Rev Med Interne; 2008 Feb; 29(2):149-51. PubMed ID: 17655981 [TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis. Chang CM; Lee NY; Lee HC; Lee IW; Wu CJ; Lin YS; Ko WC Ann Pharmacother; 2008 Apr; 42(4):580-3. PubMed ID: 18349304 [TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug. Badshah A; Janjua M; Younas F; Halabi AR; Cotant JF Am J Med Sci; 2009 Aug; 338(2):164-6. PubMed ID: 19680025 [TBL] [Abstract][Full Text] [Related]